- Home
- SRCE vs KNSA Comparison
SRCE vs KNSA Comparison
Compare SRCE & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRCE
- KNSA
- Stock Information
- Founded
- SRCE 1863
- KNSA 2015
- Country
- SRCE United States
- KNSA United Kingdom
- Employees
- SRCE N/A
- KNSA N/A
- Industry
- SRCE Major Banks
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- SRCE Finance
- KNSA Health Care
- Exchange
- SRCE Nasdaq
- KNSA Nasdaq
- Market Cap
- SRCE 1.5B
- KNSA 1.7B
- IPO Year
- SRCE N/A
- KNSA 2018
- Fundamental
- Price
- SRCE $64.92
- KNSA $21.29
- Analyst Decision
- SRCE Hold
- KNSA Strong Buy
- Analyst Count
- SRCE 2
- KNSA 5
- Target Price
- SRCE $64.75
- KNSA $36.60
- AVG Volume (30 Days)
- SRCE 78.8K
- KNSA 355.3K
- Earning Date
- SRCE 10-24-2024
- KNSA 10-29-2024
- Dividend Yield
- SRCE 2.22%
- KNSA N/A
- EPS Growth
- SRCE 2.45
- KNSA N/A
- EPS
- SRCE 5.25
- KNSA N/A
- Revenue
- SRCE $369,012,000.00
- KNSA $384,098,000.00
- Revenue This Year
- SRCE N/A
- KNSA $60.05
- Revenue Next Year
- SRCE $1.11
- KNSA $36.32
- P/E Ratio
- SRCE $12.38
- KNSA N/A
- Revenue Growth
- SRCE 1.57
- KNSA 54.41
- 52 Week Low
- SRCE $47.24
- KNSA $15.51
- 52 Week High
- SRCE $67.74
- KNSA $28.15
- Technical
- Relative Strength Index (RSI)
- SRCE 58.11
- KNSA 32.46
- Support Level
- SRCE $57.92
- KNSA $22.62
- Resistance Level
- SRCE $67.74
- KNSA $23.34
- Average True Range (ATR)
- SRCE 1.73
- KNSA 1.18
- MACD
- SRCE 0.38
- KNSA -0.19
- Stochastic Oscillator
- SRCE 71.28
- KNSA 20.27
About SRCE 1st Source Corporation
1st Source Corp along with its subsidiary offers banking services. The bank provides Commercial, Agricultural, and Real Estate Loans which are given to privately owned business clients mainly located within regional market area, Consumer Services that consists of full range of consumer banking products and services, Trust and Wealth Advisory Services and Insurance services to individuals and business clients. Its Specialty Finance Group offers financing services for construction equipment, new and pre-owned private and cargo aircraft, and various vehicle types for fleet purposes.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.